在癌症免疫治疗中KIR2DL4的新兴作用
Weimiao Li1, Guoxu Zheng2, Shuqun Zhang3
1The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, China.
Breast cancer (Tokyo, Japan)
|June 23, 2025
概括
杀手细胞免疫球蛋白类受体2DL4 (KIR2DL4) 是自然杀手 (NK) 细胞的一个关键免疫检查点. 向KIR2DL4显示出增强抗瘤免疫反应和开发新型癌症免疫疗法的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子医学是分子医学.
背景情况:
- 杀手细胞免疫球蛋白类受体2DL4 (KIR2DL4) 在自然杀手 (NK) 细胞上表达,并与人类白细胞抗原-G (HLA-G) 相互作用.
- KIR2DL4在免疫调节中发挥作用,并与各种癌症的瘤逃避有关.
- 在黑色素瘤,肺癌和卵巢癌中观察到KIR2DL4表达的升高.
研究的目的:
- 审查和讨论KIR2DL4作为癌症免疫治疗的标的潜力.
- 突出KIR2DL4在瘤免疫逃避中的作用及其作为免疫检查点的潜力.
- 探索开发新的KIR2DL4向疗法.
主要方法:
- 对研究KIR2DL4在癌症中的功能进行的文献综述.
- 在不同类型的瘤中分析KIR2DL4表达模式.
- 讨论在临床前模型中关于KIR2DL4阻断的先前发现.
主要成果:
- 阻断KIR2DL4可以使乳腺癌重新敏感于trastuzumab治疗,确定KIR2DL4作为关键的NK细胞免疫检查点.
- 在几种癌症类型中表达KIR2DL4,这表明它参与了瘤免疫逃避.
- 目前针对KIRs的治疗策略存在,但没有一个针对KIR2DL4.4特别有效.
结论:
- KIR2DL4是增强抗瘤免疫力的有希望的目标.
- 进一步了解KIR2DL4的作用可能会导致有效的针对KIR2DL4的癌症免疫疗法.
- 开发KIR2DL4向疗法可能为癌症患者提供新的治疗选择.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Cancer Vaccines
520
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
520
Cytotoxic T Cells-mediated Immune Response
2.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.5K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


